FIELD: biotechnology.
SUBSTANCE: invention relates to use of multiplied allogenic stromal stem cells of adipose tissue for treating multipass refractory complicated perianal fistula in a patient with Crohn's disease. A dose of 120 million cells is introduced in one procedure, where each pass of the fistula receives a portion of the dose, and where half the dose is introduced into the tissue surrounding the inner opening or openings, and the other half is introduced into the fistula wall along all passages of the fistula.
EFFECT: invention widens the range of equipment.
11 cl, 5 dwg, 4 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF ADIPOSE-DERIVED STROMAL STEM CELLS FOR TREATING FISTULAS | 2016 |
|
RU2744977C2 |
| USE OF ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS IN TREATING FISTULA | 2011 |
|
RU2608641C2 |
| APPLICATION OF STROMAL STEM CELLS OF FATTY TISSUE FOR FISTULA TREATMENT | 2006 |
|
RU2435846C2 |
| MESENCHYMAL STROMAL CELLS FOR TREATING SEPSIS | 2015 |
|
RU2715866C2 |
| METHOD FOR TREATMENT OF RECTAL ULCERS IN PATIENTS WITH CROHN'S DISEASE BY AUTOTRANSPLANTATION OF HEMATOPOIETIC STEM CELLS | 2022 |
|
RU2795173C1 |
| METHODS AND COMPOSITIONS FOR USE IN CELL THERAPY | 2010 |
|
RU2610427C2 |
| KOBITOLIMOD FOR USE IN TREATMENT OF INFLAMMATORY BOWEL DISEASE | 2018 |
|
RU2766356C2 |
| Tr1 CELLS, MESENCHYMAL STEM CELLS AND USING THEM | 2008 |
|
RU2493869C2 |
| METHOD OF CELL EXPANSION, METHOD OF OBTAINING CONDITIONED MEDIUM, POPULATION OF ADHESIVE MESENCHYMAL STROMAL CELLS OF PLACENTA OR ADIPOSE TISSUE, PHARMACEUTICAL COMPOSITION AND APPLICATION OF ADHESIVE MESENCHYMAL STROMAL CELLS OF PLACENTA OR ADIPOSE TISSUE IN TRANSPLANTATION | 2007 |
|
RU2433177C2 |
| APPLICATION OF APL PEPTIDE FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE AND TYPE 1 DIABETES | 2009 |
|
RU2524630C2 |
